SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                                -----------------

                                    Form 8-K

                                 CURRENT REPORT
                       PURSUANT TO SECTION 13 OR 15(d) OF
                       THE SECURITIES EXCHANGE ACT OF 1934


       Date of Report (Date of earliest event reported): February 8, 2001


                           BIOPOOL INTERNATIONAL, INC.
               (Exact Name of Registrant as Specified in Charter)


          Delaware                    0-17714                    58-1729436
(State or Other Jurisdiction        (Commission                (IRS Employer
   of Incorporation)                File Number)             Identification No.)


                              370 Interlocken Blvd.
                           Broomfield, Colorado 80021
                    (Address of Principal Executive Offices)

                                 (303) 474-2131
                         (Registrant's Telephone Number)


<PAGE>


ITEM 5.  OTHER EVENTS

     Reference  is made to the press  release  of Biopool  International,  Inc.,
d/b/a XTRANA Inc. (the "Registrant"), issued on February 8, 2001, announcing FDA
clearance of the Registrant's  MiniQuant(TM) D-dimer assay system. A copy of the
press release,  which contains information meeting the requirements of this Item
5, is attached to this Form 8-K as Exhibit  99.1 and is  incorporated  herein by
this reference.

     Further  reference is made to the press release of the Registrant issued on
February  9,  2001,   announcing  the  resignation  of  John  H.  Wheeler,   the
Registrant's  Chief  Executive  Officer.  A copy  of the  press  release,  which
contains  information  meeting the  requirements  of this Item 5, is attached to
this Form 8-K as Exhibit 99.2 and is incorporated herein by this reference.



ITEM 7.  FINANCIAL STATEMENTS AND EXHIBITS

     (a)  Financial Statements. None.

     (b)  Pro Forma Financial Information. None.

     (c)  Exhibits.

          Exhibit 99.1    Press Release of the  Registrant dated
                          February 8, 2001, announcing FDA clearance
                          of the  Registrant's MiniQuant(TM) D-dimer
                          Assay System.

          Exhibit 99.2    Press  Release  of  the  Registrant dated
                          February 9, 2001, announcing the resignation
                          of John H. Wheeler.


                                       2



<PAGE>



                                   SIGNATURES


     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.


February 12, 2001                           BIOPOOL INTERNATIONAL, INC.



                                            By:
                                                 ------------------------
                                                 Timothy Dahltorp
                                                 Chief Financial Officer


                                       3




<PAGE>




                                  EXHIBIT INDEX

EXHIBIT                                                              PAGE NUMBER
-------                                                              -----------

99.1        Press Release of the Registrant Dated                         5
            February 8, 2001, Announcing FDA Clearance
            of the Registrant's MiniQuant(TM) D-dimer
            Assay System

99.2        Press Release of the Registrant Dated                         7
            February 9, 2001 Announcing the Resignation
            of John H. Wheeler


                                       4
[{"type": "8-K", "sequence": "1", "filename": "0001.txt", "description": "8-K DATED FEBRUARY 8, 2001", "secsgml_size_bytes": 3831}]
{"company-data": {"conformed-name": "BIOPOOL INTERNATIONAL INC", "cik": "0000830736", "assigned-sic": "2835", "irs-number": "581729436", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-14257", "film-number": "1535256"}, "business-address": {"street1": "6025 NICOLLE ST SUITE A", "city": "VENTURA", "state": "CA", "zip": "93003", "phone": "8056540643"}, "mail-address": {"street1": "6025 NICOLLE STREET", "city": "VENTURA", "state": "CA", "zip": "93003"}, "former-company": {"former-conformed-name": "CYTRX BIOPOOL LTD", "date-changed": "19890716"}}
SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                                -----------------

                                    Form 8-K

                                 CURRENT REPORT
                       PURSUANT TO SECTION 13 OR 15(d) OF
                       THE SECURITIES EXCHANGE ACT OF 1934

       Date of Report (Date of earliest event reported): February 8, 2001

                           BIOPOOL INTERNATIONAL, INC.
               (Exact Name of Registrant as Specified in Charter)

          Delaware                    0-17714                    58-1729436
(State or Other Jurisdiction        (Commission                (IRS Employer
   of Incorporation)                File Number)             Identification No.)

                              370 Interlocken Blvd.
                           Broomfield, Colorado 80021
                    (Address of Principal Executive Offices)

                                 (303) 474-2131
                         (Registrant's Telephone Number)
ITEM 5.  OTHER EVENTS

     Reference  is made to the press  release  of Biopool  International,  Inc.,
d/b/a XTRANA Inc. (the "Registrant"), issued on February 8, 2001, announcing FDA
clearance of the Registrant's  MiniQuant(TM) D-dimer assay system. A copy of the
press release,  which contains information meeting the requirements of this Item
5, is attached to this Form 8-K as Exhibit  99.1 and is  incorporated  herein by
this reference.

     Further  reference is made to the press release of the Registrant issued on
February  9,  2001,   announcing  the  resignation  of  John  H.  Wheeler,   the
Registrant's  Chief  Executive  Officer.  A copy  of the  press  release,  which
contains  information  meeting the  requirements  of this Item 5, is attached to
this Form 8-K as Exhibit 99.2 and is incorporated herein by this reference.

ITEM 7.  FINANCIAL STATEMENTS AND EXHIBITS

     (a)  Financial Statements. None.

     (b)  Pro Forma Financial Information. None.

     (c)  Exhibits.

          Exhibit 99.1    Press Release of the  Registrant dated
                          February 8, 2001, announcing FDA clearance
                          of the  Registrant's MiniQuant(TM) D-dimer
                          Assay System.

          Exhibit 99.2    Press  Release  of  the  Registrant dated
                          February 9, 2001, announcing the resignation
                          of John H. Wheeler.

                                       2
SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

February 12, 2001                           BIOPOOL INTERNATIONAL, INC.

                                            By:
                                                 ------------------------
                                                 Timothy Dahltorp
                                                 Chief Financial Officer

                                       3
EXHIBIT INDEX

EXHIBIT                                                              PAGE NUMBER
-------                                                              -----------

99.1        Press Release of the Registrant Dated                         5
            February 8, 2001, Announcing FDA Clearance
            of the Registrant's MiniQuant(TM) D-dimer
            Assay System

99.2        Press Release of the Registrant Dated                         7
            February 9, 2001 Announcing the Resignation
            of John H. Wheeler

                                       4